Transforming Field Force Effectiveness with Data-Driven Territory Alignment

Background and Challenge

A specialty pharmaceutical company with a leading neurology brand (NeuraVex, a third-generation antiepileptic drug for focal seizures) faced a paradox: despite having 95 sales representatives covering the United States, the brand's prescribing growth had stalled for two consecutive quarters. Field force activity metrics looked adequate on the surface: reps were making an average of 5.2 calls per day with a 48% access rate. But beneath these averages lay a deeply uneven and inefficient territory structure that was preventing the team from reaching its commercial potential.

The company's territory alignment had been designed three years earlier using a zip-code-based approach that balanced rep headcount across geographic regions. At the time, the alignment was reasonable. But over three years, several dynamics had shifted the landscape without corresponding territory adjustments: physician practice consolidation had concentrated high-prescribing neurologists into larger academic medical centers in urban areas, new competitor launches had changed the competitive dynamics in key geographies, and the brand had won several major formulary decisions that shifted prescribing volume to different regions.

The result was a field force operating with significant structural inefficiency. Some territories contained clusters of 15-20 high-value neurologists but the rep could only reach a fraction of them within a reasonable daily drive. Other territories had very few target HCPs, leaving reps with surplus time and insufficient high-potential calls. The imbalance was dramatic: the top 20% of territories (by prescribing potential) contained 55% of the total Rx opportunity, while the bottom 20% contained only 5%.

The commercial analytics team quantified the scale of the problem. In the 12 months preceding the initiative, only 62% of Tier A (highest-value) target HCPs had received their planned call frequency of 10 or more calls per year. Meanwhile, reps in low-potential territories were averaging 7.1 calls per day (significantly above the company target of 5-6) because they were calling on lower-value physicians to fill their daily call plans. The call-to-script ratio (prescriptions generated per completed call) was 35% lower in the bottom quartile of territories compared to the top quartile, reflecting the low Rx potential of the physicians being called on.

"We had a field force of 95 reps, and about 30 of them were spending most of their time driving long distances between scattered low-value physicians, while another 20 were sitting on gold mines of high-prescribing neurologists they couldn't get to often enough. The territory map was three years out of date, and it was killing our productivity." — VP of Sales Operations

The Approach

The team undertook a 9-month initiative to redesign territory alignment using a data-driven approach that integrated multiple data sources. The project was structured in three phases: data integration and modeling, territory design and validation, and phased implementation.

Phase 1: Data Integration and Modeling (Months 1-3)

The first phase focused on building a comprehensive, multi-dimensional dataset that could inform territory design. The team integrated five data sources:

1. IQVIA Xponent Rx data: 24 months of prescription data at the individual HCP level, providing prescribing volume, trend, and new-to-brand prescription counts for all antiepileptic drugs.
2. Veeva CRM call history: 12 months of rep call activity, including completed calls, access rates, call duration, and HCP access status (open, restricted, no-see).
3. Geospatial drive time data: Point-to-point drive times between all target HCP office locations, calculated using mapping software that accounted for traffic patterns, highway access, and urban congestion.
4. HCP potential scoring: A composite score for each target HCP based on total AED prescribing volume, market share of competing brands, patient volume, and prescribing trend direction (growing vs. declining).
5. Competitive intelligence: Competitor rep count by geography, estimated competitive call frequency, and formulary status by region.

The integrated dataset covered 9,400 target HCPs across 8,200 unique practice locations. The HCP potential scoring revealed a highly skewed distribution: the top 1,200 HCPs (13% of targets) generated 52% of the total Rx opportunity, while the bottom 4,000 HCPs (43% of targets) generated only 8% of the opportunity.

Phase 2: Territory Design and Validation (Months 4-6)

Using the integrated dataset, the analytics team built an optimization model that generated territory designs to maximize three objectives simultaneously: balanced workload (each territory should require a similar number of calls to serve its target HCPs at the desired frequency), balanced opportunity (each territory should contain a similar total Rx opportunity), and geographic compactness (minimize drive time between HCP offices within each territory).

The optimization was run using a constrained clustering algorithm that grouped HCP practices into territories subject to constraints on maximum drive time between any two practices in a territory (45 minutes), minimum Rx opportunity per territory (to ensure each rep had a viable territory), and maximum HCP count per territory (to prevent overloaded territories).

The model generated three alternative territory designs, which were evaluated by a cross-functional steering committee including the VP of Sales Operations, regional sales directors, and the commercial analytics team. The selected design maintained 95 territories (no net headcount change) but reconfigured the geographic boundaries of 68 territories, including 22 major redraws that moved more than 40% of HCPs between territories.

Phase 3: Phased Implementation (Months 7-9)

Territory realignment is one of the most disruptive changes a sales organization can undergo. Reps develop relationships with their HCPs, build local market knowledge, and establish routines that are disrupted when territory boundaries change. The team managed this carefully through a phased rollout.

Month 7 focused on communication and planning. Regional directors met individually with each affected rep to explain the rationale, show the data supporting the new alignment, and address concerns. Reps were given four weeks to review their new territory maps, identify potential issues (such as key HCP relationships that would be transferred to another rep), and provide feedback.

Month 8 was the transition month. Territory changes were implemented in Veeva CRM, new call plans were generated based on the resegmented HCP lists, and reps began calling on their new territories. The team provided a two-week grace period during which performance metrics were adjusted to account for the learning curve of new geographies and HCP relationships.

Month 9 marked full operation under the new alignment, with standard performance metrics and reporting resumed.

Results

The impact of the territory realignment was measured across four dimensions: call plan completion on high-value HCPs, overall rep productivity, prescribing conversion, and workload equity.

The most impactful result was the improvement in Tier A call plan completion from 62% to 87%. This meant that the highest-value HCPs, who represented the greatest commercial opportunity, were now being called on with the planned frequency of 10 or more times per year. Under the old alignment, many Tier A HCPs were in territories where the rep had too many targets and too much drive time to reach them all. Under the new alignment, Tier A HCPs were distributed more evenly across territories, and the reduced drive times gave reps more selling hours in the day.

The call-to-script ratio improved by 18%, driven primarily by two factors. First, the reduced drive time between HCP offices meant that reps arrived at each call less rushed and better prepared, which translated into longer, more productive interactions. Average call duration increased from 4.8 minutes to 5.6 minutes. Second, the new call plans prioritized HCPs with the highest prescribing potential, ensuring that each call had a greater likelihood of converting to a prescription.

Perhaps the most surprising result was the 33% reduction in rep turnover. The company had assumed that territory disruption would lead to short-term attrition. Instead, the more balanced territories and reduced drive times improved rep satisfaction. In post-realignment surveys, 72% of reps reported that their new territory was "more manageable" or "much more manageable" than their previous one, and the number of reps reporting burnout risk declined from 28% to 11%.

"I was skeptical when they told me my territory was changing. I had spent two years building relationships with my physicians. But honestly, within two months I could see the difference. I was spending less time driving and more time in front of the right doctors. My prescription numbers went up, and I was going home earlier." — Sales Representative, Southeast Region

Key Takeaways

The territory realignment initiative has become a model for the company's other commercial brands, with two additional franchises adopting the same data-driven approach in 2026. The analytics team has developed a semi-automated territory design tool that can generate and compare alternative alignments in hours rather than weeks, enabling more frequent and responsive territory optimization.